ArticleBritish journal of pharmacology2018

Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin-dependent kinases 4 and 6 as anticancer agents.

Solomon Tadesse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.